Botulinum toxin as a therapeutic agent
References (107)
- et al.
Management of strabismus with botulinum toxin A
Ophthalmology
(1989) - et al.
Botulinum toxin tor the treatment of dysthyroid ocular myopathy
Ophthalmology
(1986) - et al.
Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients
J. Urol.
(1988) Negative antibody response to long-term treatment of facial spasm with botulinum toxin
Am. J. Ophthalmol.
(1988)- et al.
Treatment of anismus in intractable constipation with bofulinum A toxin
Lancet
(1988) - et al.
Treatment of acquired nystagmus with botulinum A toxin
Am. J. Ophthalmol.
(1988) - et al.
Calcium-dependent release of norepinephrine for permeabilized PC12 cells is inhibited by ~48 and ~112 kDa fragments of botulinum neurotoxin type E
Neuropharmacology
(1993) - et al.
Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias
Ophthalmology
(1987) - et al.
Human gene for torsion dystonia on chromosome 9q32-35
Neuron
(1989) - et al.
Botulinum toxin for achalasia
Lancet
(1993)
Dose standardization of botulinum toxin
Lancet
(1990)
Use of crystalline type A botulinum toxin in medical research
Identification of the nerve terminal targets of botulinum neurotoxin serotype-A, serotype-D, and serotype-E
J. Biol. Chem.
(1993)
Botulinum neurotoxin serotype-F is a zinc endopeptidase specific for VAMP/synaptobrevin
J. Biol. Chem.
(1993)
Double-blind study of botulinum toxin in spasmodic torticollis
Lancet
(1986)
Observations and analysis of results in 131 cases of spasmodic torticollis after selective denervation
Appl. Neurophysiol.
(1987)
Blockade of tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus
Naunyn Schmeidebergs Arch. Pharmacol.
(1980)
Interaction of 1251-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantification of distinct membrane acceptors for type A and B on motor nerves
J. Cell Biol.
(1986)
Interaction of 1251-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptormediated endocytosis
J. Cell Biol.
(1986)
Botulinum neurotoxin-C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin
EMBO J.
(1993)
Botulinum toxin injection for the treatment of oromandibular dystonia
Ann. Otol. Rhinol. Laryngol.
(1989)
Abductor laryngeal dystonia: a series treated with botulinum toxin
Laryngoscope
(1992)
Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread
Head Neck
(1990)
Phenol nerve block in the treatment of acquired spastic hemiplegia in the upper limb
J. Bone Joint Surg.
(1973)
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
Adv. Neurol
(1988)
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)
Mov. Disord.
(1989)
The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles
Cosmet. Dermatol.
(1994)
Ophthalmologic use of botulinum A exotoxin
Can. J. Ophthalmol.
(1985)
Treatment of glabellar frown lines with C. botulinum-A exotoxin
J. Dermatol. Surg. Oncol.
(1992)
Botulinum toxin in the treatment of eye disorders
B. C. Med. J.
(1991)
Botulinum toxin for benign essential blepharospasm, hemifacial spasm and agerelated lower eyelid entropion
Can. J. Neurol. Sci.
(1987)
The site and mechanism of action of botulinum neurotoxin
Treatment of focal dystonias of the hand with botulinum toxin injections
J. Neurol. Neurosurg. Psychiatry
(1989)
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance
Neurology
(1992)
Structures of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin
Earclick in palatal tremor: its origin and treatment with botulinum toxin
Neurology
(1991)
Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism
Clin. Microbiol.
(1984)
Electromyographic guidance of botulinum toxin treatment in cervical dystonia
Clin. Neuropharmacol.
(1991)
Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of mouse: differences between fast and slow muscles
J. Neurol. Neurosurg. Psychiatry
(1970)
Treatment of detrusorsphincter dyssynergia with botulinum A toxin: a double blind study
Arch. Phys. Med. Rehabil.
(1990)
Medical treatment of dystonia
Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia
Otolaryngol. Head Neck Surg.
(1990)
Botulinum toxin for relief of spasmodic dysphonia
Arch. Otolaryngol. Head Neck Surg.
(1987)
Crystalline preparation of botulinum type A (Botox®): degradation impotency with storage
Otolaryngol. Head Neck Surg.
(1993)
Enlargement of the inferior olivary nucleus in association with lesions of the central tegmental tract or dentate nucleus
Brain
(1961)
Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis
Neurology
(1989)
Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin types A, B, and E
J. Infect. Dis.
(1984)
Treatment of oromandibular dystonia with botulinum toxin
Laryngoscope
(1991)
Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes
Terminal nerve and motor end plate changes in human orbicularis muscle following botulinum A exotoxin injection
Invest. Ophthalmol. Vis. Sci.
(1990)
Cited by (88)
Passive Monoclonal and Polyclonal Antibody Therapies
2020, Immunologic Concepts in Transfusion MedicineInjectable and topical neurotoxins in dermatology: Basic science, anatomy, and therapeutic agents
2017, Journal of the American Academy of DermatologyPharmacology for the Interventional Pain Physician
2013, Practical Management of Pain: Fifth EditionBotulinum toxin injection for management of temporomandibular joint clicking
2013, International Journal of Oral and Maxillofacial SurgeryPharmacology for the interventional pain physician
2013, Practical Management of Pain: Fifth Edition
Copyright © 1996 Published by Elsevier Inc.